248 related articles for article (PubMed ID: 26169036)
1. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.
Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F
Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats.
Yildiz C; Kacan T; Akkar OB; Karakus S; Kacan SB; Ozer H; Cetin A
Reprod Sci; 2015 Nov; 22(11):1445-51. PubMed ID: 25963915
[TBL] [Abstract][Full Text] [Related]
4. Role of the protein kinase BRAF in the pathogenesis of endometriosis.
Santulli P; Marcellin L; Chouzenoux S; Boulard V; Just PA; Nicco C; Chereau C; Tosti C; Chapron C; Batteux F
Expert Opin Ther Targets; 2016 Aug; 20(8):1017-29. PubMed ID: 27087167
[TBL] [Abstract][Full Text] [Related]
5. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro.
Matsuzaki S; Darcha C
Hum Reprod; 2015 Jul; 30(7):1606-16. PubMed ID: 25976656
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis.
Moggio A; Pittatore G; Cassoni P; Marchino GL; Revelli A; Bussolati B
Fertil Steril; 2012 Dec; 98(6):1521-30.e2. PubMed ID: 22981172
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of extracellular signal-regulated kinase activity by sorafenib increases sensitivity to DNR in K562 cells.
Xiao RZ; He CM; Xiong MJ; Ruan XX; Wang LL; Chen Y; Lin DJ
Oncol Rep; 2013 May; 29(5):1895-901. PubMed ID: 23467984
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib stimulates human skin type mast cell degranulation and maturation.
Mizukami Y; Sugawara K; Kira Y; Tsuruta D
J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
Sharma I; Dhawan V; Mahajan N; Saha SC; Dhaliwal LK
Fertil Steril; 2010 Oct; 94(5):1639-46.e1. PubMed ID: 19944411
[TBL] [Abstract][Full Text] [Related]
10. VEGFR, RET, and RAF/MEK/ERK pathway take part in the inhibition of osteosarcoma MG63 cells with sorafenib treatment.
Mei J; Zhu X; Wang Z; Wang Z
Cell Biochem Biophys; 2014 May; 69(1):151-6. PubMed ID: 24375110
[TBL] [Abstract][Full Text] [Related]
11. Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 signal pathway.
Li MQ; Li HP; Meng YH; Wang XQ; Zhu XY; Mei J; Li DJ
Fertil Steril; 2012 Apr; 97(4):919-29. PubMed ID: 22265030
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of a novel sorafenib analogue, t-CUPM.
Wecksler AT; Hwang SH; Liu JY; Wettersten HI; Morisseau C; Wu J; Weiss RH; Hammock BD
Cancer Chemother Pharmacol; 2015 Jan; 75(1):161-71. PubMed ID: 25413440
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells.
Carlo-Stella C; Locatelli SL; Giacomini A; Cleris L; Saba E; Righi M; Guidetti A; Gianni AM
PLoS One; 2013; 8(4):e61603. PubMed ID: 23620775
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium derived factor inhibits the growth of human endometrial implants in nude mice and of ovarian endometriotic stromal cells in vitro.
Sun Y; Che X; Zhu L; Zhao M; Fu G; Huang X; Xu H; Hu F; Zhang X
PLoS One; 2012; 7(9):e45223. PubMed ID: 23028859
[TBL] [Abstract][Full Text] [Related]
17. CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis.
Tan CW; Lee YH; Tan HH; Lau MS; Choolani M; Griffith L; Chan JK
Fertil Steril; 2014 Jul; 102(1):167-177.e9. PubMed ID: 24825423
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
[TBL] [Abstract][Full Text] [Related]
19. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the potential therapeutic effects of a double-stranded RNA mimic complexed with polycations in an experimental mouse model of endometriosis.
García-Pascual CM; Martínez J; Calvo P; Ferrero H; Villanueva A; Pozuelo-Rubio M; Soengas M; Tormo D; Simón C; Pellicer A; Gómez R
Fertil Steril; 2015 Nov; 104(5):1310-8. PubMed ID: 26297642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
